Literature DB >> 25627089

Correlation between neovascular lesion type and clinical characteristics of nonneovascular fellow eyes in patients with unilateral, neovascular age-related macular degeneration.

Marcela Marsiglia1, Sucharita Boddu, Christine Y Chen, Jesse J Jung, Sarah Mrejen, Roberto Gallego-Pinazo, K Bailey Freund.   

Abstract

PURPOSE: To investigate the association between the type of neovascularization (NV) and the clinical characteristics of nonneovascular fellow eyes in patients with unilateral, neovascular age-related macular degeneration.
METHODS: Eighty-three patients with treatment-naive, unilateral, neovascular age-related macular degeneration were retrospectively analyzed. Neovascular lesions were classified using both fluorescein angiography and optical coherence tomography as Type 1 (subretinal pigment epithelium), 2 (subretinal), 3 (intraretinal), or mixed NV. The associations between NV lesion type and baseline clinical and imaging characteristics of the fellow eye, including central geographic atrophy, noncentral geographic atrophy, pigmentary changes, soft drusen, cuticular drusen, reticular pseudodrusen, and subfoveal choroidal thickness, were examined. Subfoveal choroidal thickness was defined as thin if thickness was <120 μm.
RESULTS: In the fellow eyes of patients with treatment-naive, unilateral, neovascular age-related macular degeneration, Type 3 NV had an increased adjusted odds ratio of reticular pseudodrusen (15.361, P < 0.001) and thin subfoveal choroidal thickness (21.537, P < 0.001) as well as a tendency toward an increased adjusted odds ratio of central geographic atrophy (4.775, P = 0.028). Fellow eyes of patients with Type 1 NV showed a decreased adjusted odds ratio of reticular pseudodrusen (0.233, P = 0.007) and thin subfoveal choroidal thickness (0.080, P = 0.005).
CONCLUSION: In patients with unilateral, neovascular age-related macular degeneration, certain nonneovascular features of the fellow eye correlate with the NV lesion composition based on type, as anatomically classified utilizing both fluorescein angiography and optical coherence tomography. Patients with Type 3 NV were more likely to have reticular pseudodrusen and/or thin subfoveal choroidal thickness in the fellow eye compared with those with Type 1 NV. Patients with Type 3 NV also showed a trend toward increased central geographic atrophy in the fellow eye.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25627089     DOI: 10.1097/IAE.0000000000000460

Source DB:  PubMed          Journal:  Retina        ISSN: 0275-004X            Impact factor:   4.256


  13 in total

1.  Prevalence, Risk, and Genetic Association of Reticular Pseudodrusen in Age-related Macular Degeneration: Age-Related Eye Disease Study 2 Report 21.

Authors:  Amitha Domalpally; Elvira Agrón; Jeong W Pak; Tiarnan D Keenan; Fredrick L Ferris; Traci E Clemons; Emily Y Chew
Journal:  Ophthalmology       Date:  2019-07-29       Impact factor: 12.079

2.  Performance characteristics of multicolor versus blue light and infrared imaging in the identification of reticular pseudodrusen.

Authors:  Josep Badal; Marc Biarnés; Jordi Monés
Journal:  Int Ophthalmol       Date:  2017-01-21       Impact factor: 2.031

3.  The Project MACULA Retinal Pigment Epithelium Grading System for Histology and Optical Coherence Tomography in Age-Related Macular Degeneration.

Authors:  Emma C Zanzottera; Jeffrey D Messinger; Thomas Ach; R Theodore Smith; K Bailey Freund; Christine A Curcio
Journal:  Invest Ophthalmol Vis Sci       Date:  2015-05       Impact factor: 4.799

4.  Do patients with unilateral macular neovascularization type 3 need AREDS supplements to slow the progression to advanced age-related macular degeneration?

Authors:  Bilal Haj Najeeb; Ursula Schmidt-Erfurth
Journal:  Eye (Lond)       Date:  2022-09-29       Impact factor: 4.456

Review 5.  Risk of geographic atrophy in age-related macular degeneration patients treated with intravitreal anti-VEGF agents.

Authors:  M Gemenetzi; A J Lotery; P J Patel
Journal:  Eye (Lond)       Date:  2016-10-07       Impact factor: 3.775

6.  Neovascular age-related macular degeneration without drusen in the fellow eye: clinical spectrum and therapeutic outcome.

Authors:  Wing H Chung; Elon H C van Dijk; Danial Mohabati; Greet Dijkman; Suzanne Yzer; Eiko K de Jong; Sascha Fauser; Reinier O Schlingemann; Carel B Hoyng; Camiel J F Boon
Journal:  Clin Ophthalmol       Date:  2016-12-21

7.  Activated Retinal Pigment Epithelium, an Optical Coherence Tomography Biomarker for Progression in Age-Related Macular Degeneration.

Authors:  Christine A Curcio; Emma C Zanzottera; Thomas Ach; Chandrakumar Balaratnasingam; K Bailey Freund
Journal:  Invest Ophthalmol Vis Sci       Date:  2017-05-01       Impact factor: 4.799

Review 8.  Spotlight on reticular pseudodrusen.

Authors:  Alessandro Rabiolo; Riccardo Sacconi; Maria Vittoria Cicinelli; Lea Querques; Francesco Bandello; Giuseppe Querques
Journal:  Clin Ophthalmol       Date:  2017-09-20

9.  Long-Term Visual Outcomes for a Treat and Extend Anti-Vascular Endothelial Growth Factor Regimen in Eyes with Neovascular Age-Related Macular Degeneration.

Authors:  Sarah Mrejen; Jesse J Jung; Christine Chen; Samir N Patel; Roberto Gallego-Pinazo; Nicolas Yannuzzi; Luna Xu; Marcela Marsiglia; Sucharita Boddu; K Bailey Freund
Journal:  J Clin Med       Date:  2015-07-08       Impact factor: 4.241

10.  Macular Atrophy Development and Subretinal Drusenoid Deposits in Anti-Vascular Endothelial Growth Factor Treated Age-Related Macular Degeneration.

Authors:  Anna V Zarubina; Orly Gal-Or; Carrie E Huisingh; Cynthia Owsley; K Bailey Freund
Journal:  Invest Ophthalmol Vis Sci       Date:  2017-12-01       Impact factor: 4.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.